Answer
Although concurrent use has not been evaluated, influenza A/B antivirals may reduce Fluenz effectiveness; delay Fluenz until 48 hours after antiviral therapy stops, antivirals within two weeks after vaccination may affect its response, and concomitant use warrants considering revaccination based on clinical judgement.
Sources for this answer
- Fluenz nasal spray suspension Influenza vaccine (live, nasal)AstraZeneca UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked